Why Esab (ESAB) is Poised to Beat Earnings Estimates Again — Positive

ESAB   Zacks Investment Research — July 23, 2025

Esab (ESAB) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Why Esab (ESAB) is Poised to Beat Earnings Estimates Again

Can Sprouts Farmers (SFM) Keep the Earnings Surprise Streak Alive? — Positive

SFM   Zacks Investment Research — July 23, 2025

Sprouts Farmers (SFM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Can Sprouts Farmers (SFM) Keep the Earnings Surprise Streak Alive?

Will Magnolia Oil & Gas Corp (MGY) Beat Estimates Again in Its Next Earnings Report? — Positive

MGY   Zacks Investment Research — July 23, 2025

Magnolia Oil & Gas Corp (MGY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Will Magnolia Oil & Gas Corp (MGY) Beat Estimates Again in Its Next Earnings Report?

Why MKS (MKSI) is Poised to Beat Earnings Estimates Again — Positive

MKSI   Zacks Investment Research — July 23, 2025

MKS (MKSI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Why MKS (MKSI) is Poised to Beat Earnings Estimates Again

Why MarketAxess (MKTX) Could Beat Earnings Estimates Again — Positive

MKTX   Zacks Investment Research — July 23, 2025

MarketAxess (MKTX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Why MarketAxess (MKTX) Could Beat Earnings Estimates Again

Will Merit Medical (MMSI) Beat Estimates Again in Its Next Earnings Report? — Positive

MMSI   Zacks Investment Research — July 23, 2025

Merit Medical (MMSI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Will Merit Medical (MMSI) Beat Estimates Again in Its Next Earnings Report?

Will Fortis (FTS) Beat Estimates Again in Its Next Earnings Report? — Positive

FTS   Zacks Investment Research — July 23, 2025

Fortis (FTS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Will Fortis (FTS) Beat Estimates Again in Its Next Earnings Report?

Will Motorola (MSI) Beat Estimates Again in Its Next Earnings Report? — Positive

MSI   Zacks Investment Research — July 23, 2025

Motorola (MSI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Will Motorola (MSI) Beat Estimates Again in Its Next Earnings Report?

Why Mettler-Toledo (MTD) is Poised to Beat Earnings Estimates Again — Positive

MTD   Zacks Investment Research — July 23, 2025

Mettler-Toledo (MTD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Why Mettler-Toledo (MTD) is Poised to Beat Earnings Estimates Again

Will Marex Group PLC (MRX) Beat Estimates Again in Its Next Earnings Report? — Positive

MRX   Zacks Investment Research — July 23, 2025

Marex Group PLC (MRX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Will Marex Group PLC (MRX) Beat Estimates Again in Its Next Earnings Report?

atai Life Sciences (NASDAQ:ATAI, ETR:9VC) is gaining momentum in the psychedelics space, with Jefferies analysts highlighting the company's potential to leapfrog rival GH Research (NASDAQ:GHRS) and establish a leading position in the treatment-resistant depression (TRD) market with its intranasal 5-MeO-DMT candidate BPL-003. The analysts maintain a ‘Buy' rating and $7 price target on atai, about double the stock's price at the time of writing.

image for news atai Life Sciences poised to lead treatment-resistant depression market with psychedelic candidate BPL-003

ZIM vs. ESEA: Which Shipping Company Should You Bet on Now? — Positive

ESEA  ZIM   Zacks Investment Research — July 23, 2025

ESEA outpaces ZIM with stronger earnings, dividend appeal and resilience amid tariff-driven trade tensions.

image for news ZIM vs. ESEA: Which Shipping Company Should You Bet on Now?

Comfort Systems to Report Q2 Earnings: Buy, Sell or Hold the Stock? — Positive

FIX   Zacks Investment Research — July 23, 2025

FIX heads into Q2 earnings with record backlog, resilient demand, and margin strength, but tough comps may slow its growth surge.

image for news Comfort Systems to Report Q2 Earnings: Buy, Sell or Hold the Stock?

Renasant Corporation (RNST) Q2 2025 Earnings Conference Call Transcript — Neutral

RNST   Seeking Alpha — July 23, 2025

Renasant Corporation (NYSE:RNST ) Q2 2025 Earnings Call July 23, 2025 10:00 AM ET Company Participants David L. Meredith - Executive Vice President James C.

image for news Renasant Corporation (RNST) Q2 2025 Earnings Conference Call Transcript

To gain an edge, this is what you need to know today.

image for news Opportunity In Japan After Breakout Triggered By Trade Deal With U.S., Trump AI Speech Ahead

Trade pact would lower tariffs on car imports from Japan to 15% from 25%, spurring hope that other countries could get similar deals

image for news Detroit Carmakers Blast Japan Trade Deal, But Their Shares Are Rallying Anyway

BlackRock Declares Quarterly Dividend of $5.21 on Common Stock — Neutral

BLK   Business Wire — July 23, 2025

NEW YORK--(BUSINESS WIRE)--BlackRock, Inc. (NYSE:BLK) today announced that its Board of Directors has declared a quarterly cash dividend of $5.21 per share of common stock, payable September 23, 2025 to shareholders of record at the close of business on September 5, 2025. About BlackRock BlackRock's purpose is to help more and more people experience financial well-being. As a fiduciary to investors and a leading provider of financial technology, we help millions of people build savings that ser.

image for news BlackRock Declares Quarterly Dividend of $5.21 on Common Stock

Boston Scientific Beats on Q2 Earnings, Raises 2025 View, Stock Up — Positive

BSX   Zacks Investment Research — July 23, 2025

BSX beats Q2 estimates, raises full-year outlook as Cardiovascular sales surge and global revenues climb 22.8%.

image for news Boston Scientific Beats on Q2 Earnings, Raises 2025 View, Stock Up

Primoris Services (PRIM) is a Great Momentum Stock: Should You Buy? — Positive

PRIM   Zacks Investment Research — July 23, 2025

Does Primoris Services (PRIM) have what it takes to be a top stock pick for momentum investors? Let's find out.

image for news Primoris Services (PRIM) is a Great Momentum Stock: Should You Buy?

Sprouts Farmers (SFM) Upgraded to Buy: Here's What You Should Know — Positive

SFM   Zacks Investment Research — July 23, 2025

Sprouts Farmers (SFM) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

image for news Sprouts Farmers (SFM) Upgraded to Buy: Here's What You Should Know